Occupational exposure limits substance evaluations
Occupational exposure limits substance evaluations
Occupational exposure limits substance evaluations
ECHA’s Committee for Risk Assessment (RAC) provides opinions on occupational exposure limits under the Carcinogens, Mutagens or Reprotoxic substances Directive (2004/37/EC) and the Chemical Agents Directive (98/24/EC) on worker protection from risks related to exposure to substances found in the workplace.
The table below provides up-to-date information on the activities planned, ongoing or completed by ECHA in relation to its work on occupational exposure limits.
There are currently no ongoing consultations.
| Boron and its compounds |
233-139-2 215-575-5 215-540-4 215-125-8 |
10043-35-3 1332-77-0 1330-43-4 1303-86-2 |
22/01/2024 | ECHA | CMRD (Directive 2004/37/EC) | Opinion development | Details |
| Cobalt and inorganic cobalt compounds | 231-158-0 | 7440-48-4 | 30/01/2023 | ECHA | CMRD (2004/37/EC) | Opinion adopted | Details |
| Silicon carbide fibres | 206-991-8 |
409-21-2 308076-74-6 |
02/04/2024 | ECHA | CMRD (Directive 2004/37/EC) | Dossier preparation | Details |
| 2-chloro-1,3-butadiene (chloroprene) | 204-818-0 | 126-99-8 | 11/12/2023 | ECHA | CMRD (Directive 2004/37/EC) | Opinion adopted | Details |
| 1,4-dioxane | 204-661-8 | 123-91-1 | 03/12/2021 | ECHA | CMD (2004/37/EC) | Opinion adopted | Details |
| 1,2-Dihydroxybenzene (Pyrocatechol) | 204-427-5 | 120-80-9 | 02/04/2024 | ECHA | CMRD (Directive 2004/37/EC) | Dossier preparation | Details |
| Acrylonitrile | 203-466-5 | 107-13-1 | 09/03/2018 | ECHA | CMD (Directive 2004/37/EC) | Opinion adopted | Details |
| 1,3-Butadiene | 203-450-8 | 106-99-0 | 28/11/2023 | ECHA | CMRD (Directive 2004/37/EC) | Opinion development | Details |
| 2,3-epoxypropyl methacrylate (glycidyl methacrylate) | 203-441-9 | 106-91-2 | 05/10/2023 | ECHA | CMRD (Directive 2004/37/EC) | Opinion adopted | Details |
| 4,4’-methylene-bis-[2-chloroaniline] (MOCA) | 202-918-9 | 101-14-4 | 29/05/2017 | ECHA | CMD (Directive 2004/37/EC) | Opinion adopted | Details |